Peri-operative acute phase response and cytokine release in women with breast cancer: Modulation by polyadenylic-polyuridylic acid

European Journal of Surgical Oncology

Volumn 25, Issue 6, 1999, Pages 574-579

  Khan, A L ^a   Larsen, F ^b   Heys, S D ^a   Eremin, O ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b IPSEN   (France)

Author keywords

Acute phase response; Polyadenylic polyuridylic acid; Synthetic polyribonucleotides

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; POLYADENYLIC POLYURIDYLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MASTECTOMY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032748516     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0709     Document Type: Article

References (25)

1. Schulz S. Humoral and neural mediators of the systemic response to surgery. Dan Med Bull. 40:1993;365-377.
2. Christou NV, Morin JE. Host defence mechanisms in elective and emergency vascular surgery: predicting sepsis-related mortality. J Vasc Surg. 3:1986;338-342.
3. Engell HC. Cancer cells in the circulating blood: a clinical study on the occurrence of cancer cells in the peripheral blood draining the tumour area at operation. Acta Chir Scand. 201-205 (Suppl. 201):1955;10-70.
4. Roberts SL, Long O, Jonasson R et al. The isolation of cancer cells from the blood stream during curettage. Surg Gynecol Obstet. 111:1960;3-11.
5. Pepys MB and ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 34:1983;141-211.
6. Baum LL, Johnson B, Berman S. C-reactive protein is involved in natural killer cell-mediated lysis but does not mediate effector-target cell recognition. Immunology. 61:1987;93-99.
7. Brittenden J, Heys SD, Ross J et al. Natural killer (NK) cells and cancer. Cancer. 77:1996;1226-1243.
8. Rosenberg SA, Lotze MT, Yang JC et al. Experience with the use of high dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg. 210:1989;474-485.
9. Worman CP, Catousky D, Bevan PC et al. Interferon is effective in hairy cell leukemia. Br J Haematol. 60:1985;759-763.
10. Wiltrout RH, Salup RR, Twilley TA, Talmadge JE. Immunomodulation of natural killer cell activity by polyribonucleotides. J Biol Resp Mod. 4:1985;512-517.
11. Hopkins SJ, Humphreys M. Bioassay of interleukin-1 in serum and plasma following removal of inhibitory activity with polyethylene glycol. J Immunol Meth. 133:1990;127-131.
12. Sternberg JC. A rate nephelometry for measuring specific proteins by immunoprecipitin reactions. Clin Chem. 23:1977;1456-1464.
13. Broom J, Heys SD et al, Eremin O. Interleukin 2 therapy in cancer: Identification of responders. Br J Cancer. 66:1992;1185-1187.
14. Bachofen VK. A review on the biological properties of C-reactive protein. Immunobiology. 183:1991;133-145.
15. Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med. 37:1992;313-337.
16. Michelson AM, Shaool D, Lacour F. Poly(A). Poly(U) as an adjuvant in cancer treatment. Distribution and pharmacokinetics in rabbits. Proc Soc Exp Biol Med. 179:1985;180-186.
17. Loughran MS, Sanderson CJ, Nossal GJ. Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5. Proc Natl Acad Sci USA. 85:1988;3115-3119.
18. Rambaldi A, Young DC, Hermann F et al. Interferon-gamma induces expression of the interleukin 2 receptor gene in human monocytes. Eur J Immunol. 17:1987;153-156.
19. Strieter RM, Remick DG, Lynch JP et al. Interleukin 2-induced tumour necrosis factor-alpha (TNF- α) gene expression in human alveolar macrophages and blood monocytes. Am Rev Respir Dis. 139:1989;335-342.
20. Kushner I. C-reactive protein and the acute phase response. Hosp Pract [Off]. 25:1990;13-28.
21. Baumann H, Gauldie J. The acute phase response. Immunol Today. 15:1994;74-80.
22. Dinarello CA. Interleukin-1 and the pathogenesis of acute phase response. N Eng J Med. 31:1984;1413-1418.
23. Perlmutter DH, Dinarello CA, Punsal PI et al. Cachectin/tumour necrosis factor regulates hepatic acute phase expression. J Clin Invest. 78:1986;1349-1353.
24. Castell JV, Gomez-Lechon MJ, David M et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 242:1989;237-239.
25. 2interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci USA. 84:1987;7629-7633.